PCSA — PROCESSA PHARMACEUTICALS INC
As of Q2 2026, 3 SEC-registered investment managers reported holding PCSA (PROCESSA PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $98.28K across 51.19K shares. That is +86.4% by share count (+23.73K shares) versus the previous quarter, while reported value moved +42.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 1 added to existing stakes, 1 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
PCSA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 22.09K | $42.41K | 0.00% | Reduce |
| Citadel Advisors history | 21.31K | $40.91K | 0.00% | New |
| UBS Group AG history | 7.79K | $14.96K | 0.00% | Add |
Q1 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 24.91K | $62.77K | 0.00% | Add |
| UBS Group AG history | 2.53K | $6.39K | 0.00% | Reduce |
| Citigroup Inc history | 14 | $35 | 0.00% | New |
| Wells Fargo & Co history | 6 | $15 | 0.00% | Hold |
Q4 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 23.59K | $67.93K | 0.00% | Reduce |
| Geode Capital Management history | 15.32K | $44.13K | 0.00% | Reduce |
| UBS Group AG history | 12.64K | $36.40K | 0.00% | New |
| Bank of America Corp history | 18 | $52 | 0.00% | Reduce |
| Wells Fargo & Co history | 6 | $17 | 0.00% | Reduce |
Q3 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 303.30K | $58.20K | 0.00% | Add |
| Vanguard Group history | 288.21K | $55.34K | 0.00% | Add |
| Citigroup Inc history | 34.05K | $6.53K | 0.00% | New |
| Bank of America Corp history | 378 | $72 | 0.00% | Add |
| Wells Fargo & Co history | 154 | $30 | 0.00% | Hold |
Q2 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 64.61K | $13.24K | 0.00% | Add |
| Geode Capital Management history | 50.57K | $10.37K | 0.00% | Add |
| Vanguard Group history | 24.43K | $5.01K | 0.00% | Hold |
| Wells Fargo & Co history | 154 | $32 | 0.00% | Hold |
| Bank of America Corp history | 108 | $22 | 0.00% | Add |
Q1 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 34.41K | $12.73K | 0.00% | Add |
| Vanguard Group history | 24.43K | $9.04K | 0.00% | Hold |
| Wells Fargo & Co history | 154 | $57 | 0.00% | Hold |
| UBS Group AG history | 56 | $21 | 0.00% | Reduce |
| Bank of America Corp history | 37 | $14 | 0.00% | Add |
New Positions (Q2 2026)
- Citadel Advisors 21.31K sh · $40.91K
Fully Exited (vs previous quarter)
- Citigroup Inc sold 14 sh · $35
- Wells Fargo & Co sold 6 sh · $15
Fund Position History — shares by quarter (top 13 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 22.09K | 24.91K | 15.32K | 303.30K | 50.57K | 34.41K | 21.98K | 19.69K | 17.24K | — | 122.03K | 152.67K | 68.83K | 68.83K | 68.83K | 64.90K | 64.90K | 64.90K | 64.90K | 64.90K |
| Citadel Advisors | 21.31K | — | — | — | — | — | — | — | — | — | 315.41K | 166.22K | 282.84K | — | — | — | — | — | — | — |
| UBS Group AG | 7.79K | 2.53K | 12.64K | — | 64.61K | 56 | 7.91K | 521 | — | 4.18K | 80.02K | 707 | — | 22.46K | — | — | — | 1.11K | 218 | 546 |
| Bank of America Corp | — | — | 18 | 378 | 108 | 37 | 25 | 24 | 21 | 160 | — | — | — | — | 14 | — | — | — | 7 | — |
| Citigroup Inc | — | 14 | — | 34.05K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | 23.59K | 288.21K | 24.43K | 24.43K | 24.43K | 24.43K | 24.43K | 24.43K | 234.65K | 344.43K | 361.68K | 361.68K | 373.83K | 373.70K | 373.60K | 373.60K | 373.60K | 373.89K |
| Wells Fargo & Co | — | 6 | 6 | 154 | 154 | 154 | 154 | 154 | 154 | 170 | 3.25K | 3.24K | 3.22K | 3.15K | 3.15K | 3.15K | 3.15K | 3.14K | 63 | 63 |
| Morgan Stanley | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 48.95K | 48.95K | 1 | — | 68 |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | — | — | 20 | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | — | 58.20K | 53.90K | 45.40K | 31.20K | 14.10K | 11.70K | 11.60K | — | — | — |
| Two Sigma Investments | — | — | — | — | — | — | — | — | — | 24.10K | 18.68K | — | — | — | — | — | — | — | — | — |
| Millennium Management | — | — | — | — | — | — | — | — | — | — | — | 25.93K | 35.19K | 50.50K | — | — | — | — | — | — |
| Northern Trust Corp | — | — | — | — | — | — | — | — | — | — | 28.14K | 15.40K | 15.40K | 15.40K | 15.40K | 15.40K | 15.40K | 15.40K | 15.40K | 15.40K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details